AwardedSpainGoods€5,993,218
Suministro de radiofarmacos para el tratamiento y diagnóstico de cáncer de próstata, lesiones suprarrenales y malabsorción de sales biliares con destino al Servicio de Medicina Nuclear del Hospital General Universitario Gregorio Marañón
- Published
- Published 12 March 2026
- Deadline
- Closed 13 April 2026
Overview
The Hospital General Universitario Gregorio Marañón procured radiopharmaceuticals for the treatment and diagnosis of prostate cancer, adrenal lesions, and bile salt malabsorption for its Nuclear Medicine Service. The contract was awarded on 14 May 2026 to Bayer Hispania, S.L.U., Curium Pharma Spain, S.A., Ge Healthcare Bio-Sciences, S.A., and Novartis Farmacéutica, S.A. for a total value of €418,019.61.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €5,993,218
- Procedure
- Open
- SME suitable
- Yes
- Published
- 12 March 2026
- Deadline
- Closed
Isotopic reagents
Award outcome
- Awarded value
- €418,020
- Award date
- 14 May 2026
- Contract period
- — → 9 May 2027
- Bayer Hispania, S.L.U.
- Curium Pharma Spain, S.A.
- Ge Healthcare Bio-Sciences, S.A.
- Novartis Farmacéutica, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
22 June 2026
Contract Notice
12 March 2026
Contracting authority
Hospital G. U. Gregorio Marañón
Procuring entityMadrid, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.